Drawing for STARSIL

USPTO serial 97184483

STARSIL

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
STEPHENS, BRIA MICHELLE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with STARSIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $498*

Plus Government fees of $250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bryan W. Bockhop

Bryan W. Bockhop BOCKHOP INTELLECTUAL PROPERTY LAW, LLC2375 MOSSY BRANCH DRIVESNELLVILLE, GA 30078United States

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical implants comprising living tissues; pharmaceutical preparations, namely, haemostatic agents, blood clotting agents, and blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; adhesive bandages with blood clotting properties; pharmaceutical preparations for the treatment of infectious diseases; haemostatic agents in the nature of medical and dental haemostatic powder for medical purposes; chemical hemostatic preparations, namely, blood clotting agents for use in improving blood coagulation and supporting natural blood cascade; chemical hemostatic preparations, namely, blood clotting powder for use in improving blood coagulation and supporting natural blood cascade; haemostatic agents, namely, haemostatic powders in the nature of medical and dental haemostatic powder for medical purposesACTIVE—
010Surgical instruments and apparatus; medical instruments and apparatus for treating all kinds of bleedings; dental instruments and apparatus for treating all kind of dental bleedings; orthopedic device for treating bleeding during orthopedic procedures; medical devices for closing wounds, namely, surgical stitches; blood clotting surgical sponge; surgical implants comprising artificial material with a blood clotting coating; blood clotting coated surgical implants from artificial materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 8, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 8, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 7, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 24, 2026EXT5SOU EXTENSION 5 FILED—
Apr 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 24, 2025EXT4SOU EXTENSION 4 FILED—
Oct 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 17, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 16, 2025EXT3SOU EXTENSION 3 FILED—
Apr 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 24, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 24, 2024EXT2SOU EXTENSION 2 FILED—
Oct 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 25, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 24, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 24, 2024EXT1SOU EXTENSION 1 FILED—
Apr 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 24, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 29, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 25, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 26, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 26, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 26, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 4, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022DOCKASSIGNED TO EXAMINER—
Dec 28, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 25, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance